Five-year biochemical control rates and late toxicity of prostate cancer hypofracionated radiotherapy

被引：0
|
作者：
Dubinsky, P. [1 ]
Belanova, K. [1 ]
Janickova, N. [1 ]
Matula, P. [1 ]
Hostova, B. [1 ]
机构：
[1] VOU As, Radiat Oncol, Kosice, Slovakia
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1333
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [1] Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication Allergies
    Turchan, William Tyler
    Gutiontov, Stanley, I
    Spiotto, Michael T.
    Liauw, Stanley L.
    [J]. JNCI CANCER SPECTRUM, 2020, 4 (06)
  • [2] Late toxicity rates following definitive radiotherapy for prostate cancer
    Ohri, Nitin
    Dicker, Adam P.
    Showalter, Timothy N.
    [J]. CANADIAN JOURNAL OF UROLOGY, 2012, 19 (04) : 6373 - 6380
  • [3] Tomotherapy with simultaneous integrated Boost in Prostate cancer: biochemical Control rates and Late toxicity
    Geinitz, H.
    Duma, M. N.
    Nieder, C.
    Kampfer, S.
    Molls, M.
    Geier, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (02) : 178 - 178
  • [4] Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study
    Potosky, AL
    Davis, WW
    Hoffman, RM
    Stanford, JL
    Stephenson, RA
    Penson, DF
    Harlan, LC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (18) : 1358 - 1367
  • [5] Stereotactic hypofracionated radiotherapy for prostate cancer patients.
    Rucinska, Monika
    Stefanczyk, Marta
    Minczewska, Joanna
    Nawrocki, Sergiusz
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] A five-year experience in conformational radiotherapy in the treatment of prostate cancer. Evaluation of acute toxicity in 131 patients.
    Nasr, E
    Merhej, S
    Nasr, DN
    Fares, G
    Moukarzel, M
    Chalouhi, E
    Bulbul, M
    Sarkis, P
    Nemr, E
    Jabbour, M
    Khoury, R
    Ghazale, G
    Chehade, G
    Ghosn, M
    Chahine, G
    Abillamah, A
    [J]. PROGRES EN UROLOGIE, 2005, 15 (01): : 36 - 39
  • [7] Urethral stricture rate after prostate cancer radiotherapy. Five-year data of a certified prostate cancer
    Kranz, J.
    Maurer, G.
    Maurer, U.
    Deserno, O.
    Schulte, S.
    Steffens, J.
    [J]. UROLOGE, 2017, 56 (03): : 336 - 341
  • [8] Stereotactic body radiotherapy for low-risk prostate cancer: Five-year outcomes
    Freeman, D.
    King, C. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [9] Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
    Maruyama, Katsuya
    Tsuji, Hiroshi
    Nomiya, Takuma
    Katoh, Hiroyuki
    Ishikawa, Hitoshi
    Kamada, Tadashi
    Wakatsuki, Masaru
    Akakura, Koichiro
    Shimazaki, Jun
    Aoyama, Hidefumi
    Tsujii, Hirohiko
    [J]. JOURNAL OF RADIATION RESEARCH, 2017, 58 (02) : 260 - 266
  • [10] Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate cancer
    Takakusagi, Yosuke
    Koge, Hiroaki
    Kano, Kio
    Shima, Satoshi
    Tsuchida, Keisuke
    Mizoguchi, Nobutaka
    Yoshida, Daisaku
    Kamada, Tadashi
    Katoh, Hiroyuki
    [J]. PLOS ONE, 2024, 19 (03):
12345